FROM:
Mark L. Tykocinski, MD
Dean, Jefferson Medical College
Senior Vice President, Thomas Jefferson University
President, Jefferson University Physicians
Thomas J. Lewis
President and CEO, Thomas Jefferson University Hospitals
Richard G. Pestell, MD, PhD, FACP, FRACP
Director, Kimmel Cancer Center
Chair, Department of Cancer Biology
Associate Dean, Cancer Related Services
We are pleased to announce the appointment of Adam P. Dicker, MD, PhD, as Chairman of the Department of Radiation Oncology Jefferson Medical College, Thomas Jefferson University, effective, May 1, 2010. He is an international authority in radiation oncology, drug development and the treatment of prostate cancer and brain tumors.
Dr. Dicker co-leads the Radiation Research and Translational Biology Program at the Kimmel Cancer Center at Thomas Jefferson University. In addition, he serves as Director of the Christine Baxter Research Laboratory for Experimental Cancer Therapies at Jefferson Medical College. Dr. Dicker has been a principal investigator in a significant number of “first in human” developmental therapeutic trials involving novel signal transduction agents and radiation therapy. He and his colleagues at Jefferson have developed new approaches to radiation therapy for the treatment of cancer, and have successfully applied their findings from the laboratory to the clinical setting.
Dr. Dicker serves as the Chair of the Translational Research Program in the Radiation Therapy Oncology Group (RTOG), a National Cancer Institute sponsored cooperative group. He formerly served as Chair of the Radiation and Cancer Biology Committee of the American Society of Therapeutic Radiation Oncology. Dr. Dicker represents the RTOG on the National Cancer Institute’s Investigational Drug Steering Committee of Cancer Treatment Evaluation Program and also serves as a consultant on cancer to the European Commission, the National Cancer Institute of Canada and the Italian Association of Cancer Research. His reputation in research and clinical practice ranks him among Philadelphia Magazine's "Top Docs" in Radiation Oncology and in Castle-Connolly America's Top Doctors for Cancer. He has published extensively and has more than 150 peer-reviewed journal articles and chapters. Dr. Dicker also serves on the editorial boards of Clinical Cancer Research, Cancer Biology, BMC Cancer and Radiation Oncology, and provides reviews for eight additional journals as well.
We are excited to welcome to our team an individual who demonstrates exceptional leadership, along with an abiding commitment to delivering high quality patient care. Dr. Dicker is a consummate physician-scientist, excelling as a clinician, teacher and investigator. Please join us in congratulating him on his appointment to his new position.